These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Significance of cytomegalovirus in blood donation]. Albert S; Kühnl P; Sibrowski W; Seidl S; Doerr HW Infusionstherapie; 1990 Feb; 17(1):48-56. PubMed ID: 2159951 [TBL] [Abstract][Full Text] [Related]
27. Occurrence of cytomegalovirus infection and factors causing reactivation of the infection among renal transplant recipients: a single center study. Khameneh ZR Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):41-5. PubMed ID: 18087121 [TBL] [Abstract][Full Text] [Related]
28. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. Razonable RR; Rivero A; Rodriguez A; Wilson J; Daniels J; Jenkins G; Larson T; Hellinger WC; Spivey JR; Paya CV J Infect Dis; 2001 Dec; 184(11):1461-4. PubMed ID: 11709790 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of a 6-week prophylactic ganciclovir regimen and the role of serial cytomegalovirus antibody testing in lung transplant recipients. Kelly JL; Albert RK; Wood DE; Raghu G Transplantation; 1995 Apr; 59(8):1144-7. PubMed ID: 7732561 [TBL] [Abstract][Full Text] [Related]
30. [Frequency of infection with cytomegaloviruses (CMV) following kidney transplantation and initial experiences with CMV gamma globulin prevention]. Kaden J; Scholz D; Eichler C; May G Immun Infekt; 1985 Nov; 13(6):290-5. PubMed ID: 3000922 [TBL] [Abstract][Full Text] [Related]
32. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors. Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730 [TBL] [Abstract][Full Text] [Related]
33. [Modification of the incidence and course of CMV infections following kidney transplantation by passive immunization--initial experiences with a hyperimmunoglobulin]. Hoyer J; Dennin RH; Schulz E Immun Infekt; 1985 Nov; 13(6):285-9. PubMed ID: 3000921 [TBL] [Abstract][Full Text] [Related]
34. Comments on CMV infections in renal transplant patients. Nankervis GA Yale J Biol Med; 1976 Mar; 49(1):27-8. PubMed ID: 183378 [No Abstract] [Full Text] [Related]
35. Intravenous immunoglobulin prophylaxis of cytomegalovirus infection in pediatric renal transplant recipients. Flynn JT; Kaiser BA; Long SS; Schulman SL; Deforest A; Polinsky MS; Baluarte HJ Am J Nephrol; 1997; 17(2):146-52. PubMed ID: 9096445 [TBL] [Abstract][Full Text] [Related]
36. Factors contributing to the risk of cytomegalovirus infection in patients receiving renal transplants. Ho M; Dowling JN; Armstrong JA; Suwansirikul S; Wu B; Youngblood LA; Saslow A Yale J Biol Med; 1976 Mar; 49(1):17-26. PubMed ID: 183377 [No Abstract] [Full Text] [Related]
37. Cytomegalovirus infection and graft survival in renal graft recipients. Cappel R; Hestermans O; Toussaint C; Vereerstraeten P; van Beers D; de Braekeleer J; Schoutens E Arch Virol; 1978; 56(1-2):149-56. PubMed ID: 204269 [TBL] [Abstract][Full Text] [Related]
38. HLA mismatching and cytomegalovirus infection as risk factors for transplant failure in cyclosporin-treated renal allograft recipients. Morris DJ; Martin S; Dyer PA; Hunt L; Mallick NP; Johnson RW J Med Virol; 1993 Dec; 41(4):324-7. PubMed ID: 8106868 [TBL] [Abstract][Full Text] [Related]
39. Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity. Weir MR; Irwin BC; Maters AW; Genemans G; Shen SY; Charache P; Williams GM Transplantation; 1987 Feb; 43(2):187-93. PubMed ID: 3027930 [TBL] [Abstract][Full Text] [Related]
40. [Prevalence of cytomegalovirus, hepatitis B and HIV-1 antibodies in healthy blood donors, hospital patients, kidney transplant recipients, i.v. drug addicts and homosexuals]. Kägi MK; Joller H; Wunderli W; Rüdlinger R; Joller-Jemelka HI Schweiz Med Wochenschr; 1989 Feb; 119(7):217-22. PubMed ID: 2540524 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]